Method Article

Protein Digestion, Ultrafiltration, and Size Exclusion Chromatography to Optimize the Isolation of Exosomes from Human Blood Plasma and Serum

16.6K views

DOI:

10.3791/57467

April 13th, 2018

In This Article

Summary

Here, we present a protocol to purify exosomes from both plasma and serum with reduced co-purification of non-exosomal blood proteins. The optimized protocol includes ultrafiltration, protease treatment, and size exclusion chromatography. Enhanced purification of exosomes benefits downstream analyses, including more accurate quantification of vesicles and proteomic characterization.

Abstract

Exosomes, a type of nanovesicle released from all cell types, can be isolated from any bodily fluid. The contents of exosomes, including proteins and RNAs, are unique to the cells from which they are derived and can be used as indicators of disease. Several common enrichment protocols, including ultracentrifugation, yield exosomes laden with soluble protein contaminants. Specifically, we have found that the most abundant proteins within blood often co-purify with exosomes and can confound downstream proteomic studies, thwarting the identification of low abundance biomarker candidates. Of additional concern is irreproducibility of exosome protein quantification due to inconsistent representation of non-exosomal protein levels. The protocol detailed here was developed to remove non-exosomal proteins that co-purify along with exosomes, adding rigor to the exosome purification process. Five methods were compared using paired blood plasma and serum from five donors. Analysis using nanoparticle tracking analysis and micro bicinchoninic acid protein assay revealed that a combined protocol utilizing ultrafiltration and size exclusion chromatography yielded the optimal vesicle enrichment and soluble protein removal. Western blotting was used to verify that the expected abundant blood proteins, including albumin and apolipoproteins, were depleted.

Introduction

Exosomes are nanovesicles (ranging in size from 30 nm to 150 nm) released by almost all the cells in the human body to facilitate cell-to-cell communication processes1,2. Interestingly, the composition of exosomes changes depending on the cells of origin as well as the health status of the individual3,4,5. Additionally, exosomes can be retrieved from several biological fluids such as: saliva, urine, and blood2. Because of these features, exosomes are considered to be a good source of disease bi....

Access restricted. Please log in or start a trial to view this content.

Protocol

This work was determined not to be human subject research upon initial review from Colorado State University's Institutional Review Board (IRB), as all human samples were obtained as de-identified samples from the Bioreclamation IVT biorepository and were collected under IRB approved protocols.

1. Preparation of Crude Sample (either Plasma or Serum) by Pelleting Larger Vesicles and Cellular Debris

Note: Safety consideration: plasma, serum, and other biological fluids are biohazardous materials and must be handled with special care, while wearing basic personal protective equipment, including gl....

Access restricted. Please log in or start a trial to view this content.

Results

The data presented below were obtained using paired plasma and serum samples from five healthy blood donors. To determine the effects of each processing step, five variations of the presented protocol were performed, and exosome recovery and non-exosome protein removal were compared. The methods trialed included: 1) SEC 700 kDa + Ultrafiltration 3 kDa; 2) Ultrafiltration 100 kDa; 3) Proteinase K + Ultrafiltration 100 kDa; 4) SEC 700 kDa + Ultrafiltration 100 kDa, and 5) Proteinase K + Ult.......

Access restricted. Please log in or start a trial to view this content.

Discussion

An optimized method to increase the purity and yield of exosomes from blood will increase the ability to accurately mine extracellular vesicles as a source of biomarkers for several diseases. The standard methods currently used to isolate exosomes, specifically, ultracentrifugation and precipitation methods, have several disadvantages including exosome aggregation and pelleting of soluble proteins7,17,18. Alternatively, the use .......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

This research was supported by internal funds from CSU (to KMD), ATCC contract #2016-0550-0002 (a subcontract of NIAID HHSN272201600013C), and The Bill and Melinda Gates Foundation (OPP1039688) (to KMD/NKG). We thank the NSF Research Experience for Undergraduates (REU) summer program at Colorado State University for additional support.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
NanosightMalvernNS300
Benchtop microcentrifuge ThermoLegend Mico21
Benchtop centrifuge Beckman CoulterAllegra 6R
Waterbath BenchmarkB2000-4
Microplate readerBIOTEKEpoch
Pierce BCA Protein Assay KitTHERMO23227
Micro BCA Protein Assay KitTHERMO23235
Phosphate buffered salineCorning21-040-CV
96 well plateCorning15705-066
Amicon Ultra-0.5 Centrifugal Filter Unit with Ultracel-100 membraneEMD-MilliporeUFC510096
Amicon Ultra-4 Centrifugal Filter UnitsEMD-MilliporeUFC800324
Capto Core 700GE Healthcare17548103
Poly-Prep Chromatography ColumnsBIORAD7311550
NuPAGE 4-12% Bis-Tris Protein GelsTHERMONP0323BOX
Nitrocellulose Membrane, Roll, 0.2 µmBIORAD1620112
Proteinase K, Tritirachium albumEMD-Millipore539480
SimplyBlue SafeStainTHERMOLC6065
SIGMAFAST BCIP/NBTMillipore-SIGMAB5655
4-Chloro-1-naphtholMillipore-SIGMAC6788
Anti-CD63 Antibody (rabbit anti-human) with goat anti-rabbit HRP secondary antibodySYSTEM BIOSCIENCESEXOAB-CD63A-1Primary and secondary antibodies
ALB Antibody (F-10)SANTA CRUZ BIOTECHNOLOGY, INC.sc-271605Primary antibody
apoB Antibody (C1.4)SANTA CRUZ BIOTECHNOLOGY, INC.sc-13538Primary antibody
apoA-I Antibody (B-10)SANTA CRUZ BIOTECHNOLOGY, INC.sc-376818Primary antibody

References

  1. Stoorvogel, W., Kleijmeer, M. J., Geuze, H. J., Raposo, G. The biogenesis and functions of exosomes. Traffic. 3 (5), 321-330 (2002).
  2. Raposo, G., Stoorvogel, W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 200 (4), 373-383 (2013).
  3. Schorey, J. S., Ha....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Exosome IsolationProteinase K TreatmentBCA AssayNanoparticle Tracking AnalysisWestern BlottingSerum SamplesVesicle Enrichment

Related Articles